Skip to content

Comparative efficacy trial of Miasmatic Totality and Polarity Analysis-based prescriptions.

A randomized comparative trial assessing the efficacy of homeopathic prescriptions based on Miasmatic Totality with Polarity Analysis on functionality impairment in migraineurs using the HIT-6 Scale. - MIGRATE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086903
Enrollment
120
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura Health Condition 2: G430- Migraine without aura

Interventions

Intervention1: Homeopathic Prescriptions based on Polarity Analysis: Individualized homoeopathic remedy selected via Polarity Analysis, based on Polarity Difference (PD) and Contraindication (CI). Rou
then modified or paused per homoeopathic guidelines, Duration: 6 months. Control Intervention1: Homeopathic Prescriptions based on Miasmatic Totality: Individualized homoeopathic remedy selected based
then modified or paused per homoeopathic guidelines, Duration: 6 months.

Sponsors

Dr Alok A Katkol
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Known cases of Migraine, diagnosed based on Simplified IHS s (The International Headache Society) classification and diagnostic criteria for primary headaches (ICHD-3). 2) Reporting a pain severity of moderate or higher on the Visual Analog Scale (VAS) for pain. 3) Cases where polar symptoms can be elicited. 4) Not on any prophylactic medication/ supplements for at least 1 month prior to inclusion in the study. 5) Willing to continue treatment with consecutive monthly follow-ups for at least 6 months from the date of inclusion into the study.

Exclusion criteria

Exclusion criteria: 1) They had a history of drug and/or alcohol abuse. 2) They are immune-compromised patients. 3) Diagnosed cases of developmental defects or congenital abnormalities. 4) Pregnant patients who are breast feeding and/or with likelihood of pregnancy. 5) There is a failure of vital organs/ systems, for example, heart, lungs, liver, kidney, and the like, as detected clinically. 6) Suffering with Chronic Migraine/ Complications of Migraine/ Probable migraine/Transformed migraine/ Chronic daily headache/Cluster headache/ Cluster migraine. 7) There is presence of any systemic (endocrinal/cardiovascular/ locomotor/neurological/hematological/psychiatric, etc.) or infectious disease(s) that the patients are already diagnosed with or detected clinically or by routine laboratory investigations. 8) Any cephalic/ non-cephalic infections, metabolic disorders, or disorders of cranial or facial structures.

Design outcomes

Primary

MeasureTime frame
To determine the change in functional impairment, assessed using the Headache Impact Test-6 (HIT-6) over a period of 6 monthsTimepoint: 3 years

Secondary

MeasureTime frame
To identify criteria that are associated with the efficacy of homeopathic remedy prescriptions based on Polarity AnalysisTimepoint: 3 Years;To determine changes in headache frequency and intensityTimepoint: 3 years

Countries

India

Contacts

Public ContactDr Alok A Katkol

SJPESs Homoeopathic Medical College and Hospital

milind_sneh@yahoo.co.in9422051639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026